Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Cash & Current Investments: 2021-2024

Historic Cash & Current Investments for Core Scientific (CORZ) over the last 4 years, with Dec 2024 value amounting to $837.0 million.

  • Core Scientific's Cash & Current Investments rose 78.66% to $453.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 billion, marking a year-over-year increase of 380.56%. This contributed to the annual value of $837.0 million for FY2024, which is 1100.68% up from last year.
  • Latest data reveals that Core Scientific reported Cash & Current Investments of $837.0 million as of FY2024, which was up 1,100.68% from $69.7 million recorded in FY2023.
  • Core Scientific's 5-year Cash & Current Investments high stood at $837.0 million for FY2024, and its period low was $52.2 million during FY2022.
  • For the 3-year period, Core Scientific's Cash & Current Investments averaged around $319.6 million, with its median value being $69.7 million (2023).
  • Per our database at Business Quant, Core Scientific's Cash & Current Investments plummeted by 60.33% in 2022 and then spiked by 1,100.68% in 2024.
  • Yearly analysis of 4 years shows Core Scientific's Cash & Current Investments stood at $131.7 million in 2021, then slumped by 60.33% to $52.2 million in 2022, then soared by 33.44% to $69.7 million in 2023, then surged by 1,100.68% to $837.0 million in 2024.